2734
RLX+ALN reduced bone turnover more than either drug alone, resulting in greater BMD increment, but whether this difference reflects better fracture risk reduction was not assessed in this study.
 bone turnover more than either drug alone, resulting in greater BMD increment: Effect; RLX+ALN: Treatment; RLX+ALN: Treatment; RLX+ALN: Treatment.Drug; RLX+ALN: Treatment.Drug; RLX+ALN: Combination.Drug; RLX+ALN: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 bone turnover more than either drug alone, resulting in greater BMD increment: Effect; RLX+ALN: Treatment; RLX+ALN: Treatment; RLX+ALN: Treatment.Drug; RLX+ALN: Treatment.Drug; RLX+ALN: Combination.Drug; RLX+ALN: Combination.Drug